# PharmaForce

> PharmaForce provides cloud-based 340B administration software and services for US hospitals, health systems and clinics, alongside pharmacy benefit management for self-insured healthcare organizations. Its products handle contract pharmacies, split billing, referral claims and reporting, with an emphasis on configurable workflows and auditable records.

- **Founded:** 2017
- **Headquarters:** Conshohocken, United States
- **Founders:** Daniel Dimitri (Co-founder; former CEO)
- **Products:** Contract Pharmacy, Split Billing, ClaimsConnect, Referrals+, PharmaForce PBM
- **Notable:** Three historical Best in KLAS wins, as listed by KLAS and the company; this is not a claim of an uninterrupted current ranking., Current company website reports 350+ covered entities.

## Products & services

- **Contract Pharmacy** — Claims qualification, restriction management, network reporting and financial analytics.
- **Split Billing** — Maps utilization to purchasing accounts, supports multi-entity inventory and records configuration changes.
- **ClaimsConnect** — Manufacturer and state Medicaid reporting, claim validation, submission tracking and reconciliation.
- **Referrals+** — Referral documentation outreach, eligibility review and reprocessing; available as software or a managed service.
- **PharmaForce PBM** — Pass-through pharmacy benefits with custom formularies and pharmacy networks for self-insured healthcare organizations.
- **RxSavingsCard** — Pharmacy-controlled prescription discount card offering.
- **Claire** — Embedded AI guidance and authorized live-data analysis in Contract Pharmacy 2.0 and Split Billing 3.0.
- **BioSelect Formulary** — PBM biosimilar formulary offering focused on clinical selection and specialty spending.

## Achievements

- Three historical Best in KLAS wins, as listed by KLAS and the company; this is not a claim of an uninterrupted current ranking.
- Current company website reports 350+ covered entities.

## Latest updates

- **2024-01** — Announced Aquiline’s majority investment, completed in Q4 2023; price undisclosed.
- **2025-02** — Daniel Dimitri discussed the company’s origin and customer-reference challenge on Founders’ Forum.
- **2026-10** — As of this research date, the website lists Rob Kill as CEO and markets Claire within Contract Pharmacy 2.0 and Split Billing 3.0; this is a current-state observation, not a launch date.

## Links

- Website: https://thepharmaforce.com/
- LinkedIn: https://www.linkedin.com/company/pharmaforcellc/
- Twitter/X: https://x.com/ThePharmaForce
- YouTube: https://www.youtube.com/@thepharmaforce
- Instagram: https://www.instagram.com/thepharmaforce/
- Facebook: https://www.facebook.com/thepharmaforce/

---

Profile page: https://yespress.io/pharmaforce
Published by YesPress — https://yespress.io
Last updated: 2026-10-02